MediciNova Announces Closing of Underwritten Public Offering of Common Stock Pharmaceutical Investing
U.S. FDA Files New Drug Application Under Priority Review for Migalastat for Treatment of Fabry Disease Biotech Investing
Reata Announces Improvements in Kidney Function With Bardoxolone Methyl Maintained for Two Years Pharmaceutical Investing
Actinium Announces Submission of IND For Actimab-A in Combination with CLAG-M Pharmaceutical Investing
Catalyst Pharmaceuticals Announces Plans to Resubmit New Drug Application for Firdapse Pharmaceutical Investing
Intercept Announces Phase 3 REVERSE Trial Evaluating OCA for the Treatment of NASH Patients Pharmaceutical Investing
Inovio and The Wistar Institute Receive More Than $4.6 Million in R&D Funding Pharmaceutical Investing
